Plasma tumor necrosis factor α levels and insulin sensitivity in hypertensive subjects

Clinical and Experimental Hypertension

Volumn 22, Issue 6, 2000, Pages 595-606

  Sheu, Wayne Huey Herng ^a,b,c   Lee, Wen Jane ^a,b,c   Chang, Ro Lin ^a,b,c   Chen, Ying Tsung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hypertension; Insulin resistance; TNF

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MUSCLE CELL; ORAL GLUCOSE TOLERANCE TEST;

CHOLESTEROL, HDL; FASTING; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033841188     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100100094     Document Type: Article

References (41)

1. Tumor necrosis factor (TNF)
2. The biology of cachectin/TNF-α primary mediator of the host response
3. Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance
4. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
5. The expression of TNF α by human muscle. Relationship to insulin resistance
6. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance
7. Insulin resistance in essential hypertension
8. Resistance to insulin stimulated-glucose uptake in patients with hypertension
9. Tumor necrosis factor- α -angiotensin interaction and regulation of blood pressure
10. Role of insulin resistance in human disease
11. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension
12. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal
13. Role of cytokines in inducing hyperlipidemia
14. Insulin resistance, glucose intolerance and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia
15. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption
16. Immunoassay of insulin and insulin antibody precipitate
17. Enzymatic determination of total serum cholesterol
18. Triglyceride: Determination after enzymatic hydrolysis
19. Precipitation methods of quantification of lipoprotein
20. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
21. Analysis of human plasma leptin by radioimmunoassay
22. Assessment of fat-free mass using bioelectrical impedance measurements of human body
23. Relation between plasma tumor necrosis factor- α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus
24. Circulating TNF- α and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity
25. Circulating tumor necrosis factor α in elevated in male but not in female patients with type II diabetes mellitus
26. Effects of an engineered human anti-TNF- α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
27. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids
28. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
29. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells
30. Tumor necrosis factor induced release of endothelial cell lipoprotein lipase
31. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension
32. Suppression of non-esterified fatty acid concentrations by insulin in patients with hypertension
33. The TNF- α gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels
34. Genetic variability in the TNF- α promoter is not associated with type II diabetes mellitus (NIDDM)
35. Linkage between obesity and a marker near the tumor necrosis factor- α locus in Pima Indians
36. Polymorphism of tumour necrosis factor-α gene, coronary heart disease and obesity
37. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro
38. In vitro production of interleukin 1, interleukin 6, and tumor necrosis factor- α in insulin-dependent diabetes mellitus
39. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsuin-dependent diabetes mellitus